[Superficial bladder carcinoma -- trend of less aggressive therapies].
Friedrich
Martin G
MG
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use; D002291:Carcinoma, Papillary / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D003558:Cystoscopy; D015251:Epirubicin / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D009364:Neoplasm Recurrence, Local; D010212:Papilloma / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin